Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Oxandrolone
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : Stin Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Oxandrolone Subdermal Implant For Rehabilitation After ACL Reconstruction
Details : Oxandrolone is a Other Small Molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of unspecified medical condition.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 16, 2025
Lead Product(s) : Oxandrolone
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : Stin Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Oxandrolone
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase III
Sponsor : US Department of Defense | Walter Reed National Military Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Placebo Versus Oxandrolone Supplementation in Trauma
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 26, 2022
Lead Product(s) : Oxandrolone
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase III
Sponsor : US Department of Defense | Walter Reed National Military Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable